Cargando…

siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine

Nucleoside metabolism enzymes are determinants of chemotherapeutic drug activity. The nucleoside salvage enzyme deoxycytidine kinase (dCK) activates gemcitabine (2′, 2′-difluoro-2′-deoxycytidine) and is negatively regulated by deoxycytidine triphosphate (dCTP). Reduction of dCTP in tumor cells could...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Cresce, Christine, Figueredo, Rene, Rytelewski, Mateusz, Vareki, Saman Maleki, Way, Colin, Ferguson, Peter J., Vincent, Mark D., Koropatnick, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673171/ https://www.ncbi.nlm.nih.gov/pubmed/26087398

Ejemplares similares

IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells
por: Maleki Vareki, Saman, et al.
Publicado: (2015)

Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined “Complementary Lethality”
por: Rytelewski, Mateusz, et al.
Publicado: (2013)

Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin
por: Vareki, Saman Maleki, et al.
Publicado: (2014)

Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2
por: Rytelewski, Mateusz, et al.
Publicado: (2016)

COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
por: Salim, Kowthar Y., et al.
Publicado: (2016)

Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines
por: Maleki Vareki, Saman, et al.
Publicado: (2018)

Correction: COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
por: Salim, Kowthar Y., et al.
Publicado: (2017)

In Vivo GFP Knockdown by Cationic Nanogel-siRNA Polyplexes
por: Shrivats, Arun R., et al.
Publicado: (2015)

bcl-2-specific siRNAs restore Gemcitabine sensitivity in human pancreatic cancer cells
por: Okamoto, Kinya, et al.
Publicado: (2007)

High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
por: Maleki Vareki, Saman
Publicado: (2018)

Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy
por: Gameiro, Steven F., et al.
Publicado: (2018)

Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice
por: De Souza, Angus T., et al.
Publicado: (2006)

Enhancing the sensitivity of the thymidine kinase assay by using DNA repair‐deficient human TK6 cells
por: Ibrahim, Mahmoud Abdelghany, et al.
Publicado: (2020)

siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo
por: Hu, Peng, et al.
Publicado: (2015)

siRNA Knockdown of RRM2 Effectively Suppressed Pancreatic Tumor Growth Alone or Synergistically with Doxorubicin
por: Zheng, Shuquan, et al.
Publicado: (2018)

SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling
por: Chen, Tai-yu, et al.
Publicado: (2022)

Case Report: Thymidine Kinase 2 (TK2) Deficiency: A Novel Mutation Associated With Childhood-Onset Mitochondrial Myopathy and Atypical Progression
por: Manini, Arianna, et al.
Publicado: (2022)

siRNA knockdown validation 101: Incorporating negative controls in antibody research
por: Olds, Will, et al.
Publicado: (2016)

Hsp70 Knockdown by siRNA Decreased Collagen Production in Keloid Fibroblasts
por: Shin, Jung U, et al.
Publicado: (2015)

Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma
por: Kundu, Anup K., et al.
Publicado: (2017)

siRNA-mediated gene knockdown via electroporation in hydrozoan jellyfish embryos
por: Masuda-Ozawa, Tokiha, et al.
Publicado: (2022)

The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer
por: Aghamajidi, Azin, et al.
Publicado: (2022)

Immunohistochemistry for Thymidine Kinase-1 (TK1): A Potential Tool for the Prognostic Stratification of Breast Cancer Patients
por: Fanelli, Giuseppe Nicolò, et al.
Publicado: (2021)

Retraction: siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo
Publicado: (2022)

Lentivirus-mediated siRNA knockdown of SPHK1 inhibits proliferation and tumorigenesis of neuroblastoma
por: Su, Lin, et al.
Publicado: (2018)

Carbon nanocarriers deliver siRNA to intact plant cells for efficient gene knockdown
por: Demirer, Gozde S., et al.
Publicado: (2020)

A novel siRNA–gemcitabine construct as a potential therapeutic for treatment of pancreatic cancer
por: Simonenko, Vera, et al.
Publicado: (2020)

Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer
por: Lo, Yi-Wen, et al.
Publicado: (2015)

Expression of Concern: siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo
Publicado: (2021)

Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker
por: Jagarlamudi, Kiran Kumar, et al.
Publicado: (2014)

Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
por: Krishnamoorthy, Mithunah, et al.
Publicado: (2021)

Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy
por: Hong, Megan M Y, et al.
Publicado: (2022)

The role of gut microbiome in immune modulation in metastatic renal cell carcinoma
por: Deluce, Jasna, et al.
Publicado: (2022)

Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies
por: Schneider, Britta, et al.
Publicado: (2012)

Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo
por: Dudek, Henryk, et al.
Publicado: (2014)

Efficient Gene Knockdown in Mouse Oocytes through Peptide Nanoparticle-Mediated SiRNA Transfection
por: Jin, Zhen, et al.
Publicado: (2016)

Fluorinated PEG-PEI Coated Magnetic Nanoparticles for siRNA Delivery and CXCR4 Knockdown
por: Cao, Yixiang, et al.
Publicado: (2022)

siRNA-Mediated MELK Knockdown Induces Accelerated Wound Healing with Increased Collagen Deposition
por: Szymanski, Lukasz, et al.
Publicado: (2023)

siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration
por: McHugh, Douglas, et al.
Publicado: (2012)

Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells
por: KUNZE, DOREEN, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m2bnhlrflvmt9bcbqfoj1uider